Your browser doesn't support javascript.
loading
The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma.
Borrello, M G; Alberti, L; Arighi, E; Bongarzone, I; Battistini, C; Bardelli, A; Pasini, B; Piutti, C; Rizzetti, M G; Mondellini, P; Radice, M T; Pierotti, M A.
Affiliation
  • Borrello MG; Divisione di Oncologia Sperimentale A, Istituto Nazionale Tumori, Milan, Italy.
Mol Cell Biol ; 16(5): 2151-63, 1996 May.
Article in En | MEDLINE | ID: mdl-8628282

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Type C Phospholipases / Tyrosine / Recombinant Fusion Proteins / Protein-Tyrosine Kinases / Proto-Oncogenes / Proto-Oncogene Proteins / Oncogene Proteins / Receptor Protein-Tyrosine Kinases / Drosophila Proteins / Isoenzymes Limits: Animals / Humans Language: En Journal: Mol Cell Biol Year: 1996 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Type C Phospholipases / Tyrosine / Recombinant Fusion Proteins / Protein-Tyrosine Kinases / Proto-Oncogenes / Proto-Oncogene Proteins / Oncogene Proteins / Receptor Protein-Tyrosine Kinases / Drosophila Proteins / Isoenzymes Limits: Animals / Humans Language: En Journal: Mol Cell Biol Year: 1996 Document type: Article